The Immunology PCS Business Development role will report to the Director of Business Development, Pipeline Commercialization Strategy, Immunology. This role will play an integral part in sourcing and evaluation of external innovation opportunities through the leadership and management of commercial assessments related to the TA strategy. This role will support due diligence on deals and driving the Immunology business development process internally and externally, targeting licensing/acquisition of key therapeutic assets, R&D collaborations, and related enabling collaborations.

Specific activities will include working with the Search & Evaluation and BD&A Transactions teams to evaluate the opportunities, and with the project team to: 1) work up the business cases, 2) develop the strategy, 3) drive commercial diligence assessment including competitive assessment, 4) guide product forecasting, and 5) lead commercial P&L generation, and 6) work with the APEX to perform market insights generation and gather secondary analytics.

The position provides the opportunity to work with a variety of key stakeholders, including but not limited to: Search and Evaluation, Licensing & Acquisition, Clinical, Discovery, Regulatory, Market Access, Health Economics, US & Global Commercial, Forecasting, Finance, and Market Research partners. Due to the cross-portfolio nature of the role, the candidate will also be involved in the preparation of other strategic initiatives, including contributions for BD strategy into the Strategic Long-Range Planning process and input into Disease Area Strategies. 

Key Responsibilities Include:

• Work with internal research, development, search and evaluation, commercial and financial analytics experts on the evaluation, due diligence, and initial product development plan for proposed transactions. This includes supporting the overall product evaluation process, including clinical / scientific assessments, evaluation of the commercial opportunity, analysis of the competitive landscape, and financial modeling
• Serve as commercial lead for internal due diligence process with Clinical, Commercial, Regulatory, Finance, Legal & IP, and Manufacturing, to conduct detailed evaluation process
• Lead commercial due diligence of external assets and ensure that tight timelines are on track
• Partner with the Pipeline Commercialization Strategy TA team, and cross functional partners on ensure BD strategies is in-line with our Disease Area strategy and immunology strategic planning, and creation of target product profiles for external asset evaluations
• Work with the APEX team to perform any market assessments needed.
• Provide commercial input on clinical development plans for external asset evaluations
• Guide the forecasting team in external asset sales modeling
• Lead the development of commercial P&Ls, including operating expense assumptions
• Frame up strategic and financial benefits of deals under evaluation
• Generate and present clear and concise commercial diligence decks to Senior Leadership
• Attend scientific and medical conferences to stay abreast of new developments in key therapeutic areas

The successful candidate will have a strong scientific, commercial, and/or clinical background and be able to understand business principles and market dynamics across various disease areas and indications within the Immunology Therapeutic Areas.